Zobrazeno 1 - 10
of 81
pro vyhledávání: '"I. M. Holdaway"'
Publikováno v:
Diabetic Medicine. 20:772-776
Endogenous hyperinsulinism as a cause for hypoglycaemia can be attributed to a number of different causes including insulinoma, sulphonylurea drugs and the newly described disorder non-insulinoma pancreatogenous hypoglycaemia (NIPH). The calcium stim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0641af4df69202e4a0af5868936b87f
https://doi.org/10.1046/j.1464-5491.2003.01033.x
https://doi.org/10.1046/j.1464-5491.2003.01033.x
Autor:
F. Boccardo, I. M. Holdaway, G. Lunglmayr, J-M Haefliger, J. E. Altwein, C.J. Tyrrell, Eberhard Varenhorst, C Jurincic-Winkler, J. P. Jordaan, F. Klippel
Publikováno v:
European Urology. 37:205-211
Objective: The aim of this study was to compare the effects of the nonsteroidal antiandrogen flutamide plus the LH–RH analogue goserelin acetate (combined androgen blockade [CAB]) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::085af750cd83834bea42be6e61159b30
https://doi.org/10.1159/000020119
https://doi.org/10.1159/000020119
Autor:
C.R. Rajasoorya, I. M. Holdaway
Publikováno v:
Pituitary. 2:29-41
Acromegaly is a consequence of chronic growth hormone (GH) excess, due in the majority of cases to a GH-secreting pituitary adenoma, and occurring with a population prevalence of 60 per million and an incidence of 3-4 per million per year. Males and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::441525450b4b30f4fba516b528734b7e
https://doi.org/10.1023/a:1009965803750
https://doi.org/10.1023/a:1009965803750
Autor:
I. M. Holdaway
Publikováno v:
Internal Medicine Journal. 31:379-381
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a04d915cc46469c6809e916c99a21c6a
https://doi.org/10.1046/j.1445-5994.2001.00101.x
https://doi.org/10.1046/j.1445-5994.2001.00101.x
Autor:
I. M. Holdaway, C.J. Tyrrell, F. Klippel, J. E. Altwein, Eberhard Varenhorst, J. P. Jordaan, M. Sotarauta, J. M. Haefliger, F. Boccardo, G. Lunglmayr
Publikováno v:
Journal of Urology. 146:1321-1326
A prospective randomized trial was conducted to compare the effects of the nonsteroidal antiandrogen flutamide (250mg. 3 times daily) plus the luteinizing hormone-releasing hormone analogue goserelin acetate (Zoladex) (3.6mg. subcutaneous depot injec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec0da63948bdb30f8afca6824ea3a3f5
https://doi.org/10.1016/s0022-5347(17)38080-1
https://doi.org/10.1016/s0022-5347(17)38080-1
Zoledronate is a newer bisphosphonate, primarily used for the treatment of tumour induced hypercalcaemia and skeletal related events in advanced bone malignancy. Bisphosphonates have been associated with a number of ocular side effects including conj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a9f916c9cca9487d3c307ec380d7cb3
https://europepmc.org/articles/PMC1860197/
https://europepmc.org/articles/PMC1860197/
Publikováno v:
Internal medicine journal. 33(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0dc89c358cc6b35d8c160f13a6f43751
https://pubmed.ncbi.nlm.nih.gov/14656239
https://pubmed.ncbi.nlm.nih.gov/14656239
Autor:
I M, Holdaway, C, Rajasoorya
Publikováno v:
Pituitary. 2(1)
Acromegaly is a consequence of chronic growth hormone (GH) excess, due in the majority of cases to a GH-secreting pituitary adenoma, and occurring with a population prevalence of 60 per million and an incidence of 3-4 per million per year. Males and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37299e2edbc2a7ab04a6f20868081a48
https://pubmed.ncbi.nlm.nih.gov/11081170
https://pubmed.ncbi.nlm.nih.gov/11081170
Autor:
C J, Tyrrell, J E, Altwein, F, Klippel, C, Jurincic-Winkler, E, Varenhorst, G, Lunglmayr, F, Boccardo, I M, Holdaway, J M, Haefliger, J P, Jordaan
Publikováno v:
European urology. 37(2)
The aim of this study was to compare the effects of the nonsteroidal antiandrogen flutamide plus the LH-RH analogue goserelin acetate (combined androgen blockade [CAB]) with goserelin acetate alone in patients with advanced prostate cancer. The origi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d01db9528f1ae827196da86f3ca04b0
https://pubmed.ncbi.nlm.nih.gov/10705200
https://pubmed.ncbi.nlm.nih.gov/10705200